SCHEMBL24089915

CCCCC[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](CCC(C)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CO)NC(=O)C(NC(=O)[C@@H](C)CC(=O)CCOCCOCCOCCOCCOCCNC(=O)CCCC[C@@H]1CC[C@H]2NC(=O)N[C@@H]12)[C@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)NC(C(=O)N[C@H](CCC(=O)O)C(=O)N[C@@H](C)C(N)=O)[C@@H](C)O

nearest known ligand 0.51

Predicted protein targets (top 8)

	gene	UniProt	supporting neighbours	confidence
▸	GLP1R	P43220	11/20	0.51

▸	RAMP3	O60896	2/20	0.47

▸	CALCR	P30988	2/20	0.47

▸	TFPI	P10646	1/20	0.46

▸	IL23R	Q5VWK5	6/20	0.46

▸	GCGR	P47871	1/20	0.46

▸	CCKBR	P32239	1/20	0.46

▸	SCTR	P47872	1/20	0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL22550672	0.88	GLP1R (0.54)	GLP1RRAMP3CALCRTFPIIL23R
SCHEMBL24089913	0.80	GLP1R (0.46)	GLP1RIL23RGCGRSCTR
SCHEMBL24089914	0.77	RAMP3 (0.51)	GLP1RRAMP3CALCRTFPI
SCHEMBL22550645	0.72	PLG (0.57)	GLP1RIL23RSCTR
SCHEMBL16922391	0.72	TFPI (0.65)	GLP1RTFPI
SCHEMBL15185973	0.72	GLP1R (0.59)	GLP1RTFPIIL23RGCGRCCKBR
SCHEMBL22550671	0.72	RAMP3 (0.53)	GLP1RRAMP3CALCR
SCHEMBL15185976	0.70	OPRM1 (0.59)	GLP1RTFPIIL23RGCGR
SCHEMBL15186077	0.70	OPRM1 (0.59)	GLP1RTFPIIL23RGCGR
SCHEMBL29440667	0.70	TFPI (0.58)	GLP1RTFPI

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20210380640-A1	SARS-CoV-2 EPITOPE-TARGETED PEPTIDE IMMUNOSTIMULANTS	INSTITUTE FOR SYSTEMS BIOLOGY	2021-12-09	—	—	US	disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

Patent	Title	Text reads most about	Predicted target · text-rank
US-20210380640-A1	SARS-CoV-2 EPITOPE-TARGETED PEPTIDE IMMUNOSTIMULANTS	ACE2, CD14, ICOSLG	GLP1R 1211/4885RAMP3 2031/4885CALCR 549/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.